Exploratory Association of 12S-HETE with Postprandial Hyperinsulinemia Rather than HOMA-IR in Women with PCOS/PMOS
- 1Department of Bromatology and Diagnostic Nutrition, Pomeranian Medical University, 70-111 Szczecin, Poland
- 2Department of Medical Chemistry, Pomeranian Medical University, 70-204 Szczecin, Poland
- 3Department of Toxicology, Dairy Technology and Food Storage, West Pomeranian University of Technology, 71-454 Szczecin, Poland
Abstract
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is one of the most commonly diagnosed endocrine disorders among women of reproductive age. The proposed term more accurately reflects the pathophysiology of the condition, emphasizing its multisystem nature rather than restricting it to ovarian dysfunction. Polycystic ovary syndrome (PCOS) is estimated to affect approximately 6–20% of women of reproductive age. The condition is characterized by considerable clinical heterogeneity, including menstrual irregularities, hyperandrogenism, difficulties conceiving, and abdominal obesity. In addition to hormonal disturbances, an important and often underestimated aspect of PMOS is its association with insulin resistance and chronic low-grade inflammation. Current evidence indicates that insulin resistance represents an important component of the pathogenesis of PMOS. In this context, the identification of biomarkers reflecting metabolic and inflammatory disturbances in affected women is of particular interest. Pro-inflammatory lipid mediators, such as hydroxyeicosatetraenoic acids (HETEs) and hydroxyoctadecadienoic acids (HODEs), are products of fatty acid oxidation and act as active modulators of the inflammatory response. Increased concentrations of these metabolites have been reported in individuals with type 2 diabetes, excessive body weight, cardiovascular diseases, and in women with PMOS. The study included 45 women diagnosed with PMOS, who were divided into groups according to the presence of insulin resistance assessed using the HOMA-IR index. Venous blood plasma was used as the biological material, and the concentrations of selected HETE and HODE metabolites were determined using high-performance liquid chromatography (HPLC). The obtained data were subjected to statistical analysis to assess the associations between lipid mediator concentrations, parameters of carbohydrate metabolism, and selected metabolic indices. Statistical analysis revealed no significant differences in the concentrations of the analyzed oxylipins (HETE and HODE) between patient groups stratified according to HOMA-IR. No significant direct correlations were observed between most of the analyzed metabolites and body mass index (BMI) or fasting blood glucose levels. However, a nominally significant association was identified for 12S-HETE (p = 0.0258), which did not remain significant after Bonferroni correction (adjusted p = 0.1806). Its concentration was nearly twofold higher in patients with PMOS who exhibited postprandial hyperinsulinemia, assessed two hours after an oral glucose tolerance test (OGTT), compared with women who had a normal insulin response. Among the seven oxylipin metabolites analyzed, only 12S-HETE showed a nominal association with postprandial hyperinsulinemia. At the same time, the findings suggest that HOMA-IR and glycemic parameters may not fully reflect changes in the oxylipin profile in patients during the early stages of metabolic dysfunction. The concentrations of several analyzed oxylipins were strongly correlated, whereas 16RS-HETE showed only weak correlations with the other metabolites. Further studies are needed to clarify the relationship between oxylipin concentrations and metabolic dysfunction in women with PCOS/PMOS.
Related
- Association between the dietary index for gut microbiota and fracture prevalence among women aged 50 years and older: a NHANES-based study with a preliminary exploratory pilot analysis.
- Acute Postprandial Glycemic Responses to Breads Made from Five Commercial Wheat-Flour Formulations: A Small Exploratory Nonrandomized Within-Participant Crossover Study
- Effects of Breakfasts with Different Carbohydrate Contents and Glycemic Index Values on Postprandial Subjective Satiety and Plasma Gut Hormone Concentrations in Healthy Adults: An Exploratory Secondary Analysis of an Acute Randomized Crossover Controlled-Feeding Study
- An exploratory simulation of the optimization of leukocyte transmigration, indicating that barrier routing is governed by context-dependent biochemical cues rather than hardwired programs
- The Lost Glucose Sink: Association of Sarcopenia Risk with Disproportionate Postprandial Glycemic Excursions in Older Adults with Type 2 Diabetes Mellitus
BibTeX
@article{szczuko2026exploratory,
title = {{Exploratory Association of 12S-HETE with Postprandial Hyperinsulinemia Rather than HOMA-IR in Women with PCOS/PMOS}},
author = {Małgorzata Szczuko and Marta Skórka-Majewicz and Wojciech Żwierełło and Aleksandra Pęcak and Leon Rudak and Urszula Szczuko and Kamila Pokorska-Niewiada},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219626},
url = {https://www.mdpi.com/1422-0067/27/21/9626},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Exploratory Association of 12S-HETE with Postprandial Hyperinsulinemia Rather than HOMA-IR in Women with PCOS/PMOS
AU - Małgorzata Szczuko
AU - Marta Skórka-Majewicz
AU - Wojciech Żwierełło
AU - Aleksandra Pęcak
AU - Leon Rudak
AU - Urszula Szczuko
AU - Kamila Pokorska-Niewiada
PY - 2026
DA - 2026/10/27
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219626
UR - https://www.mdpi.com/1422-0067/27/21/9626
AB - Polyendocrine Metabolic Ovarian Syndrome (PMOS) is one of the most commonly diagnosed endocrine disorders among women of reproductive age. The proposed term more accurately reflects the pathophysiology of the condition, emphasizing its multisystem nature rather than restricting it to ovarian dysfunction. Polycystic ovary syndrome (PCOS) is estimated to affect approximately 6–20% of women of reproductive age. The condition is characterized by considerable clinical heterogeneity, including menstrual irregularities, hyperandrogenism, difficulties conceiving, and abdominal obesity. In addition to hormonal disturbances, an important and often underestimated aspect of PMOS is its association with insulin resistance and chronic low-grade inflammation. Current evidence indicates that insulin resistance represents an important component of the pathogenesis of PMOS. In this context, the identification of biomarkers reflecting metabolic and inflammatory disturbances in affected women is of particular interest. Pro-inflammatory lipid mediators, such as hydroxyeicosatetraenoic acids (HETEs) and hydroxyoctadecadienoic acids (HODEs), are products of fatty acid oxidation and act as active modulators of the inflammatory response. Increased concentrations of these metabolites have been reported in individuals with type 2 diabetes, excessive body weight, cardiovascular diseases, and in women with PMOS. The study included 45 women diagnosed with PMOS, who were divided into groups according to the presence of insulin resistance assessed using the HOMA-IR index. Venous blood plasma was used as the biological material, and the concentrations of selected HETE and HODE metabolites were determined using high-performance liquid chromatography (HPLC). The obtained data were subjected to statistical analysis to assess the associations between lipid mediator concentrations, parameters of carbohydrate metabolism, and selected metabolic indices. Statistical analysis revealed no significant differences in the concentrations of the analyzed oxylipins (HETE and HODE) between patient groups stratified according to HOMA-IR. No significant direct correlations were observed between most of the analyzed metabolites and body mass index (BMI) or fasting blood glucose levels. However, a nominally significant association was identified for 12S-HETE (p = 0.0258), which did not remain significant after Bonferroni correction (adjusted p = 0.1806). Its concentration was nearly twofold higher in patients with PMOS who exhibited postprandial hyperinsulinemia, assessed two hours after an oral glucose tolerance test (OGTT), compared with women who had a normal insulin response. Among the seven oxylipin metabolites analyzed, only 12S-HETE showed a nominal association with postprandial hyperinsulinemia. At the same time, the findings suggest that HOMA-IR and glycemic parameters may not fully reflect changes in the oxylipin profile in patients during the early stages of metabolic dysfunction. The concentrations of several analyzed oxylipins were strongly correlated, whereas 16RS-HETE showed only weak correlations with the other metabolites. Further studies are needed to clarify the relationship between oxylipin concentrations and metabolic dysfunction in women with PCOS/PMOS.
SN - 1422-0067
ER -